Producción científica por año
Producción científica por año
Perfil de la organización
Organization profile
Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (GCCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to the understanding of causes of childhood cancer, and accelerate the translation of knowledge into novel therapies. Through discovery, development and dissemination of new scientific knowledge, GCCRI strives to have a national and global impact on the problem of childhood cancer. Our mission consists of three key areas — research, clinical and education.
Greehey Children’s Cancer Research Institute does not participate directly in patient care, but interacts with members of the Division of Pediatric Hematology-Oncology to provide support for clinical research. Research services at the Institute include: genome sequencing, small animal imaging and computational biology and bioinformatics.
Huella digital
Profundizar en los temas de investigación en los que Greehey Children's Cancer Research Institute está activo. Estas etiquetas de temas provienen de las obras de los integrantes de esta organización. Juntos, forma una huella digital única.
Colaboraciones y áreas de investigación principales de los últimos cinco años
Colaboración externa reciente a nivel de país/territorio. Para consultar los detalles, haga clic en los puntos o
Perfiles
-
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR
Han, S., Tushoski-Alemán, G. W., Zhang, P., Zheng, G., Zhou, D., Huo, Z., Licht, J., George, T. J., Allegra, C., Trevino, J. G. & Hughes, S. J., ene 2025, En: Neoplasia (United States). 59, 101070.Producción científica: Article › revisión exhaustiva
Acceso abierto -
Segregation Between an Ornamental and a Disease Driver Gene Provides Insights Into Pigment Cell Regulation
Soria, E., Lu, Q., Boswell, W., Du, K., Xing, Y., Boswell, M., Weldon, K. S., Lai, Z., Savage, M., Schartl, M. & Lu, Y., ene 2025, En: Pigment Cell and Melanoma Research. 38, 1, e13196.Producción científica: Article › revisión exhaustiva
Acceso abierto -
Advances in the treatment of BRAF-mutant low-grade glioma with MAPK inhibitors
Houghton, P. J., mar 2024, En: Translational Pediatrics. 13, 3 March, p. 513-517 5 p.Producción científica: Editorial › revisión exhaustiva
Acceso abierto1 Cita (Scopus)
Conjuntos de datos
-
Additional file 8: Figure S7. of MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1
Cirilo, P. D. R. (Creator), de Sousa Andrade, L. N. (Contributor), Corrêa, B. R. S. (Creator), Qiao, M. (Creator), Furuya, T. K. (Contributor), Chammas, R. (Creator) & Penalva, L. O. F. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3927946_d8, https://springernature.figshare.com/articles/figure/Additional_file_8_Figure_S7_of_MicroRNA-195_acts_as_an_anti-proliferative_miRNA_in_human_melanoma_cells_by_targeting_Prohibitin_1/5593174
Dataset
-
MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1
Cirilo, P. D. R. (Creator), de Sousa Andrade, L. N. (Contributor), Corrêa, B. R. S. (Contributor), Qiao, M. (Creator), Furuya, T. K. (Contributor), Chammas, R. (Creator) & Penalva, L. O. F. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3927946, https://figshare.com/collections/MicroRNA-195_acts_as_an_anti-proliferative_miRNA_in_human_melanoma_cells_by_targeting_Prohibitin_1/3927946
Dataset
-
Solution structure of the extracellular domain of the TGF-beta type I receptor
Zuniga, J. E. (Contributor), Ilangovan, U. (Contributor), Mahlawat, P. (Contributor), Hinck, C. S. (Contributor), Huang, T. (Contributor), Groppe, J. C. (Contributor), McEwen, D. G. (Contributor) & Hinck, A. P. (Contributor), Protein Data Bank (PDB), oct 26 2011
DOI: 10.2210/pdb2L5S/pdb, https://www.wwpdb.org/pdb?id=pdb_00002l5s
Dataset